EP Patent

EP2680873A2 — Antifungal agents and uses thereof

Assigned to Cidara Therapeutics Inc · Expires 2014-01-08 · 12y expired

What this patent protects

The invention features echinocandin class compounds. The compounds can be useful for the treatment of fungal infections.

USPTO Abstract

The invention features echinocandin class compounds. The compounds can be useful for the treatment of fungal infections.

Drugs covered by this patent

rezafungin-acetate (REZAFUNGIN ACETATE)

Patent Metadata

Patent number: EP2680873A2
Jurisdiction: EP
Classification: —
Expires: 2014-01-08
Drug substance claim: No
Drug product claim: No
Assignee: Cidara Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.